PUK15 a Managed Care Cost-Offset Model for Ferric Citrate, an Experimental Phosphate Binder That Can Reduce the Use of Erythropoiesis-Stimulating Agents and Intravenous Iron in Hemodialysis Patients With Hyperphosphatemia

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.03.835
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2015English

Intravenous Iron and Erythropoiesis-Stimulating Agents in Haemodialysis: A Systematic Review and Meta-Analysis

Nephrology
MedicineNephrology
2017English

Intravenous Iron Versus Oral Iron Versus No Iron With or Without Erythropoiesis- Stimulating Agents (ESA) for Cancer Patients With Anaemia: A Systematic Review and Network Meta-Analysis

Cochrane Database of Systematic Reviews
2017English

The Phosphate Binder Ferric Citrate Alters the Gut Microbiome in Rats With Chronic Kidney Disease

Journal of Pharmacology and Experimental Therapeutics
Molecular MedicinePharmacology
2018English

Randomized Clinical Trial of the Iron-Based Phosphate Binder PA21 in Hemodialysis Patients

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2012English

Ferric Citrate Hydrate for the Treatment of Hyperphosphatemia in Nondialysis-Dependent CKD

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2014English

Potentially Modifiable Factors Associated With Non-Adherence to Phosphate Binder Use in Patients on Hemodialysis

BMC Nephrology
Nephrology
2013English

PCN34 Cost Analysis of Anemia Treatment With Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in Italy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2011English

DGI-043 Increased Cost of Erythropoiesis-Stimulating Agents in Some Special Situations

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy